Qmed Asia has successfully raised MYR5.1 million ($1.16 million) through an equity crowdfunding (ECF) campaign in Leet Capital.
Qmed Asia has attracted support from 110 investors, including angel investors, the Malaysia Co-Investment Fund (MyCIF) and 1337 Ventures.
The company is well-positioned for regional expansion into markets such as Indonesia and Saudi Arabia, while also driving the development of our deep-tech solutions in medical artificial intelligence (AI).
Qmed Asia (formerly QueueMed) is founded by a group of doctors and engineers to assist both public and private healthcare providers with their digital health transformation.
Qmed Asia’s journey began as an appointment booking and mobile live queue system provider for the healthcare industry, and during the pandemic, they became the official partner for the operations of 42 COVID-19 vaccination centers, signing key partnerships with consumer giant Nestlé Malaysia and property firm SP Setia Group.
Qmed Copilot is an AI-powered clinical assistant that empowers healthcare professionals to make faster and more accurate diagnosis.
By leveraging technology, Copilot allows doctors and clinicians to identify patterns and trends in patient data, effectively reducing diagnostic errors and ultimately improving patient outcomes.
The firm has been enabling investors to invest in highly vetted, high-growth businesses whilst providing an avenue for high-growth businesses to raise capital.